This activity offers CE credit for:
- Physicians (CME)
- Pharmacists (CPE)
- Nurses (CNE)
- Other
Credit Expiration Date: Sunday, July 26, 2020
 | David W. Dodick, MD Professor Department of Neurology Mayo Clinic Phoenix, AZ |
Statement of Need
This video is a replay of a plenary session from the 11th Annual Chair Summit Master Class for Neuroscience Professional Development held in Ft. Lauderdale, FL on February 7-9, 2019.
Learning Objectives
At the end of this CME activity, participants should be able to:
- Incorporate evidence-based tools and strategies into routine practice to improve the differential diagnosis of migraine.
- Integrate safety and efficacy data on novel strategies for migraine prevention and acute treatment into treatment decisions.
- Implement essential components of shared decision-making from the National Quality Forum (NQF) Playbook to develop individualized treatment strategies to mitigate the burden of migraine.
The following learning objective pertain only to those requesting CNE or CPE credit:
- Identify evidence-based tools and strategies that can be incorporated into routine practice to improve the differential diagnosis of migraine.
Financial Support
This activity is supported by an educational grant from Teva Pharmaceuticals.
Target Audience
Physicians, physician assistants, nurse practitioners, pharmacists, certified case managers, social workers, and other non-physician health care professionals with an interest in psychiatry, neurology, and the neurosciences.
Credit Information
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CME Outfitters designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1 contact hours.
Note to Nurse Practitioners: Nurses can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1 contact hours (0.10) CEUs). Universal Activity Number: Enduring: 0376-0000-19-034-H01-P
Type: knowledge-based.
Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.
Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit https://www.cmeoutfitters.com/privacy-and-confidentiality-policy
Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Dodick reports that he is a consultant for Alder Pharmaceuticals, Inc.; Allergan; Amgen Inc.; Autonomic Technologies Inc.; Biohaven Pharmaceuticals; Dr. Reddy's Laboratories, Inc.; electroCore, LLC; Eli Lilly and Company; eNeura Inc.; Impel NeuroPharma, Inc.; Ipsen Biopharmaceuticals, Inc.; Neurolief Ltd.; Novartis Pharmaceuticals Corporation; Satsuma Pharmaceuticals, Inc.; Teva Pharmaceuticals USA; Theranica Bio-Electronics LTD; W.L. Gore & Associates, Inc.; and Zosano Pharma Corporation. He receives equity from Aural Analytics; EPIEN Medical, Inc.; Healint; Mobile Health Management Services, Inc.; Nocira; Ontologics; and Theranica Bio-Electronics LTD. He holds Patent 17189376.1-1466: vTitle: Botulinum Toxin Dosage Regimen for Chronic Migraine Prophylaxis. He receives professional society fees or reimbursement for travel from the American Academy of Neurology; American Brain Foundation; American Headache Society; American Migraine Foundation; and International Headache Society.
Howard Bliwise, MD (peer reviewer) has no disclosures to report.
Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS(877.263.7767).
CHV-079-072619-15
